Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
/PRNewswire/ -- Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced...
Stay updated with breaking news from Isaac Chow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced...
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an...
Facility to produce immunotherapy drugs for cancer treatment in global market. Read more at straitstimes.com.
By Reuters Staff 2 Min Read KUALA LUMPUR (Reuters) - Shares in AirAsia Group Bhd fell in morning trade on Tuesday, as analysts lowered earnings forecasts after the Malaysian budget airline group posted its record quarterly loss. FILE PHOTO: Airasia planes are seen parked at Kuala Lumpur International Airport 2, amid the coronavirus disease (COVID-19) outbreak in Sepang, Malaysia October 6, 2020. REUTERS/Lim Huey Teng The stock fell as much as 6.2% in the first half session of trade. Affin Hwang Capital cut earnings forecasts for 2021 and 2022, expecting a larger net loss this year due to lock...